Publications by authors named "Haya Sidis"
Clin Exp Rheumatol
January 2022
Article Synopsis
- The study investigates how biologics (TNFα, IL-17A, and IL-6R blockers) affect T cell function in patients with psoriatic arthritis (PsA) compared to healthy controls.
- Findings show that adalimumab (ADA) significantly reduces activated T cells in PsA patients, while other biologics like ixekizumab (IXE) and tocilizumab (TCZ) have different effects.
- The research suggests that ADA is more effective in inhibiting T cell proliferation and identifies potential reasons behind TCZ's lower effectiveness in treating PsA.
